102 related articles for article (PubMed ID: 6618899)
1. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
Kodama M; Tanaka T
Hiroshima J Med Sci; 1983 Jun; 32(2):167-71. PubMed ID: 6618899
[No Abstract] [Full Text] [Related]
2. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
Okano Y; Takenaka A; Kasugai H; Morii T; Kishigami Y; Okuda S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1892-3. PubMed ID: 6882009
[No Abstract] [Full Text] [Related]
3. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
4. [Clinical investigation of intratumoral OK-432 administration].
Shimada K; Tabuse K; Kono N; Katsumi M; Yamamoto H; Yamamoto Y; Endo A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1844-9. PubMed ID: 6882008
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
6. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
Hanaue H; Nomoto S; Seto A; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):1975-85. PubMed ID: 7169568
[No Abstract] [Full Text] [Related]
8. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
[No Abstract] [Full Text] [Related]
9. The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
Sakamoto J; Kondo T; Kamei H; Ichihashi H; Yamamura Y
Nagoya J Med Sci; 1979 Dec; 42(1-2):27-36. PubMed ID: 530302
[No Abstract] [Full Text] [Related]
10. [A case of bronchial carcinoma showing regression upon intratumoral administration of OK-432].
Onodera A; Miura K; Sasaki M; Sugiyama N; Kurokawa H; Shioya T; Kanazawa T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):341-4. PubMed ID: 3341793
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
[TBL] [Abstract][Full Text] [Related]
12. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
[No Abstract] [Full Text] [Related]
13. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
[No Abstract] [Full Text] [Related]
14. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
Hanaue H; Kurosawa T; Miyakawa S; Horie F; Nemoto A; Yamoto H; Nishimura S; Tsuchiya H; Miura S; Asagoe T
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2271-8. PubMed ID: 3879494
[No Abstract] [Full Text] [Related]
15. [Treatment of advanced cervical cancer with sequential administration of OK-432].
Yakabe A; Sugino N; Yamashita S; Kinashi N; Ito T; Kamei T; Takasaki A
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1911-4. PubMed ID: 3209918
[No Abstract] [Full Text] [Related]
16. [Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].
Imaoka S; Sasaki Y; Matsui Y; Ishikawa O; Taniguchi K; Iwanaga T; Terasawa T
Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1957-62. PubMed ID: 6298326
[No Abstract] [Full Text] [Related]
17. [A case of recurrence of gastric cancer with an abdominal wall tumor responding to intratumoral OK-432 administration].
Saeki T; Kuninobu H; Niimoto M; Hattori T; Ohoya M; Yoshida H; Sata H; Kajitani Y
Gan No Rinsho; 1987 Apr; 33(4):417-20. PubMed ID: 2952818
[TBL] [Abstract][Full Text] [Related]
18. [Changes in peripheral lymphocyte subsets before and after OK-432 administration in liver cancer].
Yamamoto S; Omoto K; Yamamoto R; Ideguchi S; Oumi T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1077-8. PubMed ID: 3963851
[No Abstract] [Full Text] [Related]
19. [Investigation on the adequate administration interval with OK-432, using the cytotoxicity test].
Tsukuda M; Furukawa S; Yoshida T; Yanoma S; Watanabe A; Takahashi K; Ono T; Sawaki S
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):423-5. PubMed ID: 2930206
[No Abstract] [Full Text] [Related]
20. [Hemodynamic effects of a large dose injection of OK-432 (picibanil)].
Morita K; Murata T; Marumoto M; Tsuboi H; Nakahara Y; Oda T; Mohri H
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):295-300. PubMed ID: 6674797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
